Curcumin and Curcumol Inhibit NF-κB and TGF-β₁/Smads Signaling Pathways in CSE-Treated RAW246.7 Cells

Abstract

E-Zhu (Curcuma zedoaria) is known as a classical traditional Chinese medicine and widely used in the treatment of cancers, cardiovascular disease, inflammation, and other diseases. Its main components include curcumol and curcumin, which have anti-inflammatory and antifibrosis effects. Here we established an in vitro inflammatory injury model by stimulating RAW246.7 cells with cigarette smoke extract (CSE) and detected the intervention effects of curcumin and curcumol on CSE-treated Raw246.7 macrophage cells to explore whether the two compounds inhibited the expression of inflammatory cytokines by inhibiting the NF-κB signaling pathway. We detected the antifibrosis effects of curcumin and curcumol via TGF-β1/Smads signaling pathways. The model of macrophage damage group was established by CSE stimulation. Curcumol and curcumin were administered to Raw246.7 macrophage cells. The efficacy of curcumol and curcumin was evaluated by comparing the activation of proinflammatory factors, profibrotic factors, and NF-κB and TGF-β1/Smads signaling pathway. In addition, CSE-treated group was employed to detect whether the efficacy of curcumol and curcumin was dependent on the NF-κB signaling via the pretreatment with the inhibitor of NF-κB. Our findings demonstrated that curcumol and curcumin could reduce the release of intracellular ROS from macrophages, inhibit the NF-κB signaling pathway, and downregulate the release of proinflammatory factor. Curcumol and curcumin inhibited the TGF-β1/Smads signaling pathway and downregulated the release of fibrotic factors. Curcumin showed no anti-inflammatory effect in CSE-treated cells after the inhibition of NF-κB. Curcumol and curcumin showed an anti-inflammatory effect by inhibiting the NF-κB signaling pathway.

Curcumin improves memory deficits by inhibiting HMGB1‐RAGE/TLR4‐NF‐κB signalling pathway in APPswe/PS1dE9 transgenic mice hippocampus

“… 42 There is a low basal COX2 expression in neurons of the healthy brain; however, pathological conditions, such as astrocyte activation, strongly induce COX2 in the brain. 43 The prevention of astrocyte activation and inhibition of HMGB1, RAGE and TLR4, as shown in our study, together with NF‐κB inhibition by curcuma , reported previously, 40 , 44 point to the fact that its anti‐inflammatory effects may play an important role in the development of AD. In clinical trials, curcumin appears to have no major side effects in patients with AD.…”

Curcumin attenuates inflammation and cell apoptosis through regulating NF-κB and JAK2/STAT3 signaling pathway against acute kidney injury

“…NF-κB is one of the targets for Curcumin. Curcumin inhibits the NF-κB signaling pathway, and reduces the release of proinflammatory factors in RAW246.7 cells treated by cigarette smoke extracts [20]. Inhibition of NF-κB may be the main mechanism for the anti-inflammatory effect of Curcumin [21].…”

Curcumol enhances the anti-tumor effects of metformin via suppressing epithelial-mesenchymal transition in triple-negative breast cancer

“…Structurally, however, curcumol and curcumin differ, which suggests that they might possess different bioactivity (19). For example, the inhibitory effect of curcumol on the production of inflammatory factors in RAW246.7 cells was more significant than that of curcumin (20). Currently, the effects of the combination of curcumol and metformin on the progression of TNBC are unclear.…”